Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.17%
- Poor long term growth as Net Sales has grown by an annual rate of 7.63% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.61 times
Negative results in Mar 26
With ROCE of 2.8, it has a Very Expensive valuation with a 19.3 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.31% of the company
Stock DNA
Specialty Chemicals
INR 1,902 Cr (Micro Cap)
818.00
21
0.00%
0.32
8.95%
27.22
Total Returns (Price + Dividend) 
Indokem for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Indokem Ltd Shares Show Mixed Technical Signals Amid Price Momentum Shift
Indokem Ltd, a micro-cap player in the specialty chemicals sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a strong day gain of 4.97%, the company’s technical indicators present a complex picture, with bullish signals on monthly charts contrasting with mixed weekly and daily readings. This article analyses the recent technical parameter changes, price momentum, and how these developments position Indokem relative to broader market benchmarks.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
01-Aug-2026 | Source : BSEPursuant to Regulation 47 of SEBI(LODR) Regulations 2015 we enclose herewith the copies of Newspaper advertisements regarding extract of Unaudited Financial Results for the quarter ended 30th June 2026 as approved by the board of directors of the company in its meeting held on Friday 31st july 2026.
Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 31St July 2026
31-Jul-2026 | Source : BSEPursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that the Board of Directors at its Meeting held today has approved the matter as mentioned in the enclosed intimation.
Results- Financial Results For 30Th June 2026
31-Jul-2026 | Source : BSEThe Unaudited Standalone and Consolidated financial results for the quarter ended 30th June 2026 were approved by the Board of Directors at its meeting held today.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 10 Schemes (0.1%)
Held by 0 FIIs
Vindhyapriya Holdings Pvt Ltd (19.76%)
Sangeetha S (1.79%)
25.52%
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
YoY Growth in quarter ended Jun 2026 is 12.17% vs 12.41% in Jun 2025
YoY Growth in quarter ended Jun 2026 is 52.86% vs 150.72% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 1.99% vs -5.01% in Sep 2024
Growth in half year ended Sep 2025 is 180.43% vs 72.67% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.18% vs -0.87% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 337.50% vs 87.67% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -4.89% vs 8.06% in Mar 2025
YoY Growth in year ended Mar 2026 is -41.01% vs 151.21% in Mar 2025